Sretenka Dokich, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 949 Palm Ave, Imperial Beach, CA 91932 Phone: 619-429-3733 |
News Archive
Celtaxsys, a clinical stage drug development company focused on advancing care for patients suffering from orphan inflammatory diseases, announced today the commencement of the US arm of an international phase 2 clinical trial for its flagship compound, acebilustat, in patients with cystic fibrosis (CF).
UT Southwestern Medical Center will take part in a national clinical trial to test a device that could provide relief for people suffering from tinnitus, a persistent buzzing or ringing sound in the ears. The device uses nervous system stimuli to rewire parts of the brain, in hopes of significantly reducing or removing tinnitus.
People who end up in the emergency room because of a fall often are tripped up by an infection, rather than a loose throw rug or poor eyesight, suggests a study being presented at IDWeek 2015.
The Accelerated Community Oncology Research Network (ACORN), a national oncology clinical trial network, has announced that it is bridging the disparity gap in healthcare to underserved communities by enrolling more than double the national average of African Americans in cancer-related clinical trials.
Oncothyreon Inc. today announced that Merck KGaA, Darmstadt, Germany, has initiated the international Phase 3 START2 study, which is designed to assess the efficacy and safety of the investigational MUC1 antigen-specific cancer immunotherapy tecemotide (also known as L-BLP25) in patients with unresectable, locally advanced Stage III non-small cell lung cancer (NSCLC).
› Verified 9 days ago